Total Raised: ₹2,550 Cr
Number of Deals: 23
Top 5 Deals Accounted For: ₹1,797 Cr (~70% of the week’s funding)
India’s startup funding momentum picked up pace in the second week of August 2025, with ₹2,550 Cr raised across 23 deals. Investor appetite leaned towards healthtech, lifestyle brands, and mobility, a blend of growth-stage scale-ups and established players attracting strategic capital. Let’s look at the top 5 fundraisers:
🔝 Top 5 Deals of the Week
Date | Company | Trade Name | Deal Size (₹ Cr) | Investors/Buyers | Location |
---|---|---|---|---|---|
11 Aug 2025 | Intellihealth Solutions Private Limited | Truemeds | 744 | Info Edge Ventures, Westbridge Capital Partners, Peak XV Partners, Accel India | Mumbai |
14 Aug 2025 | Aditya Birla Digital Fashion Ventures Limited | TMRW | 437 | ServiceNow Ventures | Mumbai |
13 Aug 2025 | Aragen Life Sciences Limited | Aragen | 300 | Avendus Capital, SBI Life Insurance Company Limited | Hyderabad |
12 Aug 2025 | Ultraviolette Automotive Private Limited | Ultraviolette Automotive | 184 | TDK Ventures, Zoho Corporation, Lingotto | Bangalore |
12 Aug 2025 | Kimirica Lifestyle Private Limited | Kimirica | 132 | Carnelian Asset Management LLP | Indore |
📝 Note: All figures are based on press announcements. MCA filings are awaited.
Key Insights
1. Healthtech Steals the Spotlight
Truemeds’ ₹744 Cr Series C, led by marquee investors like Westbridge, Accel, and Peak XV, was the week’s largest deal, reflecting strong investor conviction in tech-enabled, affordable healthcare distribution. Late-stage capital here signals readiness for nationwide scale and possible IPO positioning.
2. Corporate-backed Fashion Bets
Aditya Birla’s TMRW raised ₹437 Cr from ServiceNow Ventures, showing that corporate-led lifestyle platforms can still pull in sizable growth capital. This aligns with the rise of digital-first fashion ecosystems integrating tech with retail.
3. Deep Science & Pharma R&D Funding
Aragen’s ₹300 Cr raise underscores investor interest in contract research and pharma manufacturing, a sector benefiting from global demand for Indian R&D capabilities.
4. EV & Mobility Still Hot
Ultraviolette’s ₹184 Cr funding from global and domestic players reinforces the EV two-wheeler segment’s long-term potential, especially when paired with strong brand positioning and proprietary tech.
5. Premium Lifestyle & Hospitality Brands Attracting Capital
Kimirica’s ₹132 Cr infusion shows that investors are willing to bet on premium, experience-driven brands in personal care and hospitality, especially those with strong export potential.
What’s the Signal?
Healthtech is scaling fast – With Truemeds leading the charge, and as investor confidence in digital healthcare marketplaces grows, the sector is now moving into aggressive expansion phases.
Strategic and corporate funds are active – Moreover, the TMRW and Aragen deals show that both corporate-backed ventures and B2B-heavy models are attracting equal investor attention, reinforcing the diversity of capital flows.
Mobility innovation continues – Furthermore, Ultraviolette’s EV push highlights that mobility remains a high-conviction category, even though the space demands significant capital investments.
Premium brand plays are thriving – Lastly, Kimirica’s raise is part of a broader trend where experience-led, high-margin consumer brands are increasingly drawing strong investor interest, both domestically and globally.
Real-time Monitoring
Want early signals on startup fundraises, before the news hits?
Track verified MCA filings, startup financials, and investor insights in real-time with PrivateCircle Research.